| ²é¿´: 403 | »Ø¸´: 0 | |||
Ê黽ºþгæ (СÓÐÃûÆø)
|
[½»Á÷]
ÌåÄÚתȾµÄ·½·¨ÓëÃâÒßϵͳ¼²²¡¶à·¢ÐÔÓ²»¯£¨MS£©Ñо¿
|
| ¶à·¢ÐÔÓ²»¯£¨Multiple sclerosis£¬MS£©ÊÇÖÐÊàÉñ¾ÏµÍ³µÄÒ»ÖÖÂýÐÔÍÑËèÇÊÐÔÉñ¾±äÐÔ¼²²¡¡£ËäÈ»MSµÄÈ·Çз¢²¡»úÖÆÉв»Çå³þ£¬µ«CD4 + Tϸ°û½éµ¼µÄ×ÔÉíÃâÒß±»ÈÏΪÊÇ·¢²¡»úÖÆÖÐ×îÖØÒªµÄ·½ÃæÖ®Ò»¡£²¸È鶯Îï·Ç±àÂëmicroRNAs£¨miRNAs£©¿É²ÎÓëÃâÒßϵͳµÄ¹¦ÄÜ¡£miR-155µÄ±í´ïÓ벡È˶෢ÐÔÓ²»¯Ö¢¼²²¡µÄÑÏÖØ³Ì¶ÈºÍСÊóʵÑéÐÔ×ÔÉíÃâÒßÐÔÄÔ¼¹ËèÑ×£¨EAE£©¸ß¶ÈÏà¹Ø¡£ÏÖ·ÖÏíһƪÔËÓÃÌåÄÚתȾmiRNA-155£¨Entranster-in vivo£©µÄ·½·¨Ñо¿ÃâÒßϵͳ¼²²¡¶à·¢ÐÔÓ²»¯£¨MS£©µÄÎÄÏ×£¬ÒÔ¹©²Î¿¼¡£ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : MicroRNA-155_Modulates_Th1_and_Th17_Cell_Differentiation_and_is_Associated_with_Multiple_Sclerosis_and_Experimental_Autoimmune_Encephalomyelitis.pdf
2019-03-26 09:43:33, 1.52 M
» ²ÂÄãϲ»¶
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ50È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
ÇâÑõ»¯¼Ø»î»¯²Ù×÷
ÒѾÓÐ18È˻ظ´
É¢½ð
ÒѾÓÐ68È˻ظ´
ÉúÎïÖʳ¬¼¶µçÈÝÆ÷
ÒѾÓÐ0È˻ظ´









»Ø¸´´ËÂ¥